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To celebrate the 60th anniversary of SCIENCE CHINA, the 
second issue of Science China Life Sciences (2010) focuses 
on immunology, with six articles contributed by immunolo-
gists working both in and outside China. The articles review 
the current position and recent developments in the field of 
immunology, including tumor necrosis factor (TNF) recep-
tor-associated factor (TRAF) family molecules, innate 
recognition, plasmacytoid dendritic cells (pDCs), costimu-
latory molecules, T cells, and humanized mouse models. 
As early as 1798, the word “vaccination” was coined 
specifically to describe the injection of smallpox vaccine. In 
1880, Louis Pasteur published a paper on Pasteurella sep-
tica cholera, heralding the beginning of a new scientific 
field: Immunology. From then on, Pasteur’s germ theory of 
human infectious disease facilitated the development of 
various vaccines, leading to a greater understanding of the 
immune system which, in turn, resulted in the expansion of 
the field of Immunology. For a century, immunologists 
around the world have enhanced our understanding of the 
immune system; from humoral and cellular adaptive im-
munity to the pattern recognition involved in innate immun-
ity. Alongside great advances due to the expansion of mo-
lecular biology over the past decade, Immunology has be-
come a central pillar of the life sciences, developing many 
branches such as Medical Immunology, Tumor Immunolo-
gy, Clinical Immunology and Transplantation Immunology. 
As an integral component of medical science, Immunology 
plays an important role in deepening the understanding of 
the pathophysiology of human disease, and also contributes 
to the development of modern therapeutics to treat infection, 
autoimmune diseases, allergies and cancer. In recent years, 
Chinese immunologists have produced many important 
studies in Immunology. The following reviews provide a 
brief overview of recent advances in Immunology, high-
lighting the contributions of leading Chinese immunolo-
gists. 
The first review “TRAF-mediated regulation of immune 
and inflammatory responses” by Wang et al. [1] focuses on 
the TRAF family, beginning with a comprehensive intro-
duction to structure and function. Over the past few years, 
research studies have established a central role of TRAF 
proteins in inflammation and immunity. The TRAF family 
plays divergent and non-redundant roles in regulating the 
many signal transduction pathways involved in innate and 
adaptive immune responses. These molecules participate in 
signal transduction by a large number of receptor families, 
including the TNF receptor family and the Toll-like recep-
tor-interleukin-1 receptor family. The review summarizes 
the divergent roles played by TRAF proteins in positive and 
negative regulation of the canonical and non-canonical 
NF-κB pathways and type I interferon pathways, and also 
points out many aspects of TRAF biology that, although not 
clear, may still be of great significance to related research. 
The second review is entitled “On self-non-self discrim-
ination in pattern recognition” by Liu et al. [2]. The first 
section of this article discusses the development of immun-
ity from a historical perspective. The second part deals with 
two different patterns of innate immune recognition. The 
third part then goes on to summarize the latest advances in 
the authors’ own research into the CD24-SiglecG/10 path-
way. According to their studies, the CD24/Siglec 10 path-
way discriminates pathogen-associated molecular patterns 
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from danger-associated molecular patterns, enabling a 
cross-reactive pattern recognition pathway to initiate im-
munity against pathogens without significant immune-  
mediated self-destruction to the tissues [3,4]. Although re-
cent studies have greatly enhanced our understanding of the 
CD24/Siglec 10 pathway, there are still several challenging 
questions that remain to be answered. 
pDCs are unique and essential immune cells capable of 
producing large amounts of type I interferons in response to 
viral infection [5,7]. The third review entitled “Plasmacy-
toid dendritic cells in antiviral immunity and autoimmunity” 
by Tang et al. [8] focuses on the molecular mechanisms 
underlying pDC activity in antiviral immunity and autoim-
munity. The review summarizes the remarkable progress 
made over the past 10 years in understanding pDC biology, 
and provides a detailed introduction to pDC biology, in-
cluding their discovery, characterization, and function in 
antiviral immunity and autoimmunity. Because of the im-
portance of pDCs to antiviral immunity and autoimmunity 
[9,10], future research will lead to novel therapeutic ap-
proaches to the induction of human antiviral immunity and 
the treatment of autoimmune diseases. 
The next review entitled “Structural immunology of 
costimulatory and coinhibitory molecules” by Wang 
ShengDian and Chen LiePing [11] focuses on the T cell 
costimulatory pathways that play a critical role in regulating 
the immune response. In recent years, several co-signaling 
pathways have been identified [12,13]. An explosion of 
research into costimulation has resulted in incredible growth 
in the understanding of the molecular structures involved, 
and has provided the basis for further understanding of T 
cell costimulatory pathways and the subsequent develop-
ment of therapeutic interventions. This review describes in 
detail the structure of co-signaling molecules in the context 
of their function and therapeutic application. Predictably, as 
research progresses, gradually increasing understanding of 
the structure of costimulatory and co-inhibitory molecules 
will provide further impetus to the study of the biological 
function of costimulatory pathways, and encourage their 
therapeutic application. 
The current understanding is that T cells activate innate 
immune cells to clear pathogens. Surprisingly, it has be-
come evident that T cells also take part in regulating innate 
immune responses during the early phases of infection [14]. 
A review by Tong Hong and Fu Yangxin entitled “A new 
role for T cells in dampening innate inflammatory respons-
es” [15] provides us with a new perspective on T cells. This 
review cites evidence suggesting that conventional T cells 
temper acute innate inflammation, and elaborates upon the 
recent finding that effector and memory T cells dampen the 
hyperactive inflammasome during the late phase of the pri-
mary response or upon secondary challenge. These unex-
pected results suggest that T cells within the adaptive im-
mune arm regulate innate responses; thus, shedding new 
light on the evolution and interplay between the innate and 
adaptive immune systems [16]. Further understanding of the 
underlying mechanisms will facilitate the clinical diagnosis 
and treatment of various infectious and inflammatory dis-
eases. 
Mice with a reconstituted human immune system, and 
other human target organs, are very important for research 
into human-tropic pathogens. As such, a number of hu-
man-mouse chimeric models (incorporating human immune 
cells) have been developed over the past 20 years, but with 
only limited success. In the final review in this series enti-
tled “Current humanized mouse models for studying human 
immunology and HIV-1 immuno-pathogenesis”, Zhang et al. 
[17] summarize the current understanding of HIV-1 im-
munopathogenesis in human patients and SIV-infected pri-
mate models. The authors review recent progress in the de-
velopment of humanized mouse models with a functional 
human immune system, particularly the recent progress in 
the development of immunodeficient mice that carry a de-
fective gamma-C gene. 
Alongside the development of the national economy and 
other sciences in China, immunology has developed rapidly 
over the past ten years. Compared with the limited amount 
prior to this, immunology research in China is now both 
extensive and comprehensive, covering all aspects from 
basic theory to clinical research, and the development and 
application of immunological techniques. Many excellent 
Chinese immunologists have emerged over recent years and 
have produced remarkable work in the field, including the 
structural basis and mechanisms of immune recognition, 
immunological therapy, influenza, and inflammasomes. The 
work on Toll-like receptors, which mediate both innate and 
adaptive immune responses by recognizing molecules ex-
pressed by invading pathogens and eliciting immune re-
sponses, has greatly enhanced our understanding of in-
flammation [18,19]. Studies of influenza have also helped 
the fight against the threat of flu [20–23]. The development 
of monoclonal antibody techniques has facilitated the de-
velopment of modern therapeutics for related diseases 
[24–26] and research on HIV has brought new opportunities 
to cure AIDS [27,28]. 
When we look at the overall standard of immunology re-
search in China, there is still a gap when compared with that 
in developed countries, mainly due to a lack of originality 
and innovation. However, constantly increasing input and 
increased attention means that immunology in China should 
experience a leapfrogging in terms of development in the 
near future. We hope that this special focus on immunology 
in this issue of SCIENCE CHINA Life Sciences will help to 
achieve this. 
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